
Dynavax Technologies Corporation DVAX
$ 10.86
-0.37%
Quarterly report 2025-Q3
added 11-05-2025
Dynavax Technologies Corporation P/E Ratio 2011-2025 | DVAX
Annual P/E Ratio Dynavax Technologies Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.3 | -252 | 4.64 | 19.7 | -8.45 | -2.36 | -4.32 | -9.07 | -1.32 | -7.42 | -4.96 | -5.18 | -7.36 | -9.11 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.3 | -252 | -16 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
-15.6 K | $ 223.98 | -0.53 % | $ 396 B | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-6.11 | $ 4.67 | 1.74 % | $ 775 M | ||
|
Aclaris Therapeutics
ACRS
|
-1.15 | $ 3.36 | 2.75 % | $ 260 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 210.16 | 4.43 % | $ 5 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
-0.958 | $ 1.33 | -1.48 % | $ 7.25 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.42 | 2.09 % | $ 8.23 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8.2 | $ 25.9 | 0.74 % | $ 1.25 B | ||
|
AstraZeneca PLC
AZN
|
706 | $ 90.29 | - | $ 96.9 B | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 9.49 | - | $ 139 M | ||
|
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.333 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.28 | - | $ 14.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
Biogen
BIIB
|
11.9 | $ 172.5 | - | $ 25.1 B | ||
|
Baudax Bio
BXRX
|
-0.0133 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Benitec Biopharma
BNTC
|
-63.2 | $ 12.96 | 1.17 % | $ 533 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
50.4 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
106 | $ 581.03 | 2.22 % | $ 44 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 0.29 | -0.31 % | $ 631 M | ||
|
Checkpoint Therapeutics
CKPT
|
-2.85 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.179 | - | -16.75 % | $ 25.8 M | ||
|
Catalyst Biosciences
CBIO
|
-0.393 | $ 15.31 | - | $ 1.01 B | ||
|
Clovis Oncology
CLVS
|
-0.873 | - | -7.23 % | $ 13 M | ||
|
Cerus Corporation
CERS
|
-14.4 | $ 2.15 | 13.76 % | $ 397 M | ||
|
BioVie
BIVI
|
-0.139 | $ 1.51 | -4.43 % | $ 2.23 M | ||
|
Cortexyme
CRTX
|
-2.23 | - | -1.05 % | $ 67.1 M | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.94 | - | $ 1.8 M | ||
|
Cellectar Biosciences
CLRB
|
-1.04 | $ 3.78 | -5.97 % | $ 46.2 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-6.15 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.2 | $ 11.44 | 7.92 % | $ 740 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 96.0 | - | $ 27.2 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
-0.171 | - | -5.68 % | $ 8.28 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Enochian Biosciences
ENOB
|
-0.649 | - | - | $ 40.5 M | ||
|
Epizyme
EPZM
|
-0.409 | - | - | $ 249 M |